P0749 Infection adverse events with tulisokibart over 50 weeks of treatment in the phase 2 Crohn’s disease APOLLO-CD trialJoão Sabino, B G Feagan, L Peyrin-Biroulet et al.|Journal of Crohn s and Colitis|2025Cited by 1